Open Access Policy and Licencing

As from volume 57 in 2023 the Scandinavian Journal of Urology is published Open Access, and authors retain full copyright to their manuscript. Articles are then published immediately upon approval of the final proof and payment of the publication fee. All articles are assigned a DOI number (Digital Object Identifier).

Scandinavian Journal of Urology articles are published under a Creative Commons Attribution Non-Commercial license (CC-BY-NC 4.0 licence). This allows for the non-commercial reuse of the published paper as long as the published paper is fully attributed. Commercial re-use can only be undertaken with the permission of the publisher.

Authors who are required by their funders or Open Access agreements to publish their articles under a Creative Commons Attribution (CC-BY 4.0 licence) license have the option of doing so upon request. This license permits the reuse for commercial purposes, but still requires that the article is fully attributed.

When publishing articles in Scandinavian Journal of Urology, the author(s) grant first publication rights to Acta Chirurgica Scandinavica. In consideration of the publication of the article, the authors grant to Scandinavian Journal of Urology the licence to 1) publish, reproduce, distribute, display and store the article worldwide in all forms, formats and media now known or as developed in the future, including print, electronic and digital forms, and 2) to translate the article into other languages, create adaptations, summaries or extracts of the article. Please note that authors are themselves responsible for obtaining permission for reproducing copyrighted material from other sources.

Commercial use of articles published under the CC-BY-NC licence

All commercial requests to re-use the article in whole or in part will be handled by the Acta Chirurgica Scandinavica. Any permission fees will be retained by this organization. For the purposes of these terms, “commercial use” means use in any manner that is primarily intended for or directed toward commercial advantage or monetary compensation, including but not limited to provision or distribution (including by way of hyperlink) of the article (including any abstract, figures or tables) in any format. For further information on commercial use of published papers please contact us.